Feng et al. [14] found that deletion of the CDKN2A/B was highly prevalent in pediatric ALL patients and had a detrimental effect on the prognosis of pediatric B-ALL patients, serving as an independent risk factor for poor prognosis. Here, CDKN2A is linked to acute lymphoblastic leukemia.